首页 > 最新文献

Türk Yoğun Bakım Dergisi最新文献

英文 中文
Hemodiafiltration Practice in a Patient with Severe Amitriptyline Intoxication 1例严重阿米替林中毒患者的血液滤过治疗
Pub Date : 2018-07-16 DOI: 10.4274/tybd.32559
Ülkü Sabuncu, R. Abdullayev, M. Duran, Abuzer Güler, H. Kuşderci
Tricyclic antidepressants (TADs) are widely used drugs for different indications such as depression, neuropathic pain, nocturnal enuresis, obsessive-compulsive, panic and attention deficit hyperactivity disorders. These agents are the most prescribed drugs following selective serotonin reuptake inhibitors for depression (1). Taken in high doses either on purpose or accidentally they can result in serious morbidity and mortality. Data of 2008 from Turkey’s National Poison Consultation Center reveals that amitriptyline ranks 3rd, after paracetamol and combined upper respiratory tract infection treatment drugs, according to the classification made by reference active ingredient (2). Amitriptyline increases noradrenaline and serotonin levels by inhibiting their reuptake from the synaptic cleft (3). It also blocks adrenergic, histaminergic, central and peripheral cholinergic receptors. Toxicity symptoms are the results of the effects of amitriptyline in different systems. Dryness and metallic taste in the mouth, mydriasis, constipation, urinary retention, respiratory depression, and decreased cognitive functions and tachycardia occur due to the cholinergic receptor blockade. Weight gain, sedation and depression ABSTRACT Tricyclic antidepressants are widely used drugs for treatment of depression despite serious mortality and morbidity in higher doses. They can cause severe cardiac arrhythmias, hypotension and central nervous system depression. Some patients may remain unresponsive in spite of conventional therapies such as gastric lavage and activated charcoal administration, benzodiazepines, volume replacement, lidocaine and sodium bicarbonate infusion. In this paper we report a 20-year-old female patient who had severe amitriptyline intoxication with a Glasgow Coma Scale score 4 and severe cardiac arrhythmias and was treated with hemodiafiltration. Conventional therapy was inadequate and hemodiafiltration was applied to the patient for 36 hours. At the end of the 36-hours the patient was conscious and became stabilized in terms of hemodynamics. In case of serious intoxication that does not respond to conventional therapy, approaches like hemodialysis, plasmapheresis, hemoperfusion and hemodiafiltration can be a rescue therapy and they should be considered.
三环抗抑郁药(TADs)是广泛应用于抑郁症、神经性疼痛、夜间遗尿、强迫症、恐慌症和注意缺陷多动障碍等不同适应症的药物。这些药物是继选择性5 -羟色胺再摄取抑制剂之后最常用的治疗抑郁症的药物(1)。无论是有意还是无意,服用高剂量的药物都会导致严重的发病率和死亡率。土耳其国家中毒咨询中心2008年的数据显示,根据参考活性成分的分类,阿米替林排名第三,仅次于扑热息痛和联合上呼吸道感染治疗药物(2)。阿米替林通过抑制去甲肾上腺素和血清素从突触间隙的再摄取来提高它们的水平(3)。阿米替林还能阻断肾上腺素、组胺、中枢和外周胆碱能受体。毒性症状是阿米替林在不同系统中的作用的结果。胆碱能受体阻断可导致口腔干燥和金属味、流涕、便秘、尿潴留、呼吸抑制、认知功能下降和心动过速。三环类抗抑郁药是广泛应用于抑郁症治疗的药物,尽管高剂量会导致严重的死亡率和发病率。它们会导致严重的心律失常、低血压和中枢神经系统抑郁。尽管采用传统的治疗方法,如洗胃和活性炭、苯二氮卓类药物、容量替代、利多卡因和碳酸氢钠输注,一些患者仍可能无反应。在本文中,我们报告了一位20岁的女性患者,她患有严重的阿米替林中毒,格拉斯哥昏迷评分为4分,并伴有严重的心律失常,并接受了血液滤过治疗。常规治疗不充分,对患者进行血液滤过治疗36小时。36小时后,患者恢复意识,血流动力学稳定。在严重中毒的情况下,常规治疗无效,血液透析、血浆置换、血液灌流和血液滤过等方法可以作为一种抢救治疗方法,应予以考虑。
{"title":"Hemodiafiltration Practice in a Patient with Severe Amitriptyline Intoxication","authors":"Ülkü Sabuncu, R. Abdullayev, M. Duran, Abuzer Güler, H. Kuşderci","doi":"10.4274/tybd.32559","DOIUrl":"https://doi.org/10.4274/tybd.32559","url":null,"abstract":"Tricyclic antidepressants (TADs) are widely used drugs for different indications such as depression, neuropathic pain, nocturnal enuresis, obsessive-compulsive, panic and attention deficit hyperactivity disorders. These agents are the most prescribed drugs following selective serotonin reuptake inhibitors for depression (1). Taken in high doses either on purpose or accidentally they can result in serious morbidity and mortality. Data of 2008 from Turkey’s National Poison Consultation Center reveals that amitriptyline ranks 3rd, after paracetamol and combined upper respiratory tract infection treatment drugs, according to the classification made by reference active ingredient (2). Amitriptyline increases noradrenaline and serotonin levels by inhibiting their reuptake from the synaptic cleft (3). It also blocks adrenergic, histaminergic, central and peripheral cholinergic receptors. Toxicity symptoms are the results of the effects of amitriptyline in different systems. Dryness and metallic taste in the mouth, mydriasis, constipation, urinary retention, respiratory depression, and decreased cognitive functions and tachycardia occur due to the cholinergic receptor blockade. Weight gain, sedation and depression ABSTRACT Tricyclic antidepressants are widely used drugs for treatment of depression despite serious mortality and morbidity in higher doses. They can cause severe cardiac arrhythmias, hypotension and central nervous system depression. Some patients may remain unresponsive in spite of conventional therapies such as gastric lavage and activated charcoal administration, benzodiazepines, volume replacement, lidocaine and sodium bicarbonate infusion. In this paper we report a 20-year-old female patient who had severe amitriptyline intoxication with a Glasgow Coma Scale score 4 and severe cardiac arrhythmias and was treated with hemodiafiltration. Conventional therapy was inadequate and hemodiafiltration was applied to the patient for 36 hours. At the end of the 36-hours the patient was conscious and became stabilized in terms of hemodynamics. In case of serious intoxication that does not respond to conventional therapy, approaches like hemodialysis, plasmapheresis, hemoperfusion and hemodiafiltration can be a rescue therapy and they should be considered.","PeriodicalId":392452,"journal":{"name":"Türk Yoğun Bakım Dergisi","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129986952","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Evaluation of the Effects of Erythrocyte Transfusion on Central Venous Oximetry in Major Surgery Patients 大手术患者红细胞输注对中心静脉血氧测定的影响
Pub Date : 2018-07-16 DOI: 10.4274/TYBD.95914
E. Gasimov, Ahmet K Koltka, N. Sivrikoz, A. Çamcı
{"title":"The Evaluation of the Effects of Erythrocyte Transfusion on Central Venous Oximetry in Major Surgery Patients","authors":"E. Gasimov, Ahmet K Koltka, N. Sivrikoz, A. Çamcı","doi":"10.4274/TYBD.95914","DOIUrl":"https://doi.org/10.4274/TYBD.95914","url":null,"abstract":"","PeriodicalId":392452,"journal":{"name":"Türk Yoğun Bakım Dergisi","volume":"94 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129232081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute Renal Failure Due to Metformin Intoxication: Case Report 二甲双胍中毒致急性肾功能衰竭1例
Pub Date : 2018-07-16 DOI: 10.4274/TYBD.26818
Ç. Kocaoğlu, A. Ozel
{"title":"Acute Renal Failure Due to Metformin Intoxication: Case Report","authors":"Ç. Kocaoğlu, A. Ozel","doi":"10.4274/TYBD.26818","DOIUrl":"https://doi.org/10.4274/TYBD.26818","url":null,"abstract":"","PeriodicalId":392452,"journal":{"name":"Türk Yoğun Bakım Dergisi","volume":"16 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127688650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
The Effect of Extensively Drug-resistant Infections on Mortality in Surgical Intensive Care Patients 广泛耐药感染对外科重症监护患者死亡率的影响
Pub Date : 2018-07-16 DOI: 10.4274/TYBD.73636
Helin Şahintürk, A. Ozdemirkan, F. Kilic, Onur Ozalp, H. Arslan, P. Zeyneloğlu, A. Pirat
Objective: The aim of the study was to assess the outcomes of intensive care unit acquired extensively drug-resistant (XDR) bacterial infections in a surgical patient cohort. Materials and Methods: The data of patients with XDR bacteria isolated at Başkent University Hospital, Anesthesia and Surgical Intensive Care Unit between January 2016 and December 2016 were reviewed retrospectively. Adult patients over 18 years of age who had undergone surgery within the first 24 hours and who developed intensive care unit infection 48 hours after admission to intensive care unit were included in the study. Results: All of the 341 patients who admitted to the surgical intensive care unit during the study period were underwent surgery within the first 24 hours. XDR bacterial infections were isolated in 30 out (9%) of these 341 patients. The mean APACHE II score was calculated as 18.5±5.3, and expected mean mortality rate of 35±17.1. The mean length of intensive care unit stay was 27.0±27.4 days, while the mean hospital stay was 49.0±34.3 days. The hospital mortality rate was found to be 57% (n=7). Conclusion: As a conclusion of our study, we found that XDR bacterial infections were common (9%) among intensive care surgical patients and their mortality rate was higher than their expected mortality rate according to their APACHE II scores calculated during intensive care unit admission (57% vs. 35%, respectively).
目的:本研究的目的是评估重症监护病房获得性广泛耐药(XDR)细菌感染在外科患者队列中的结果。材料与方法:回顾性分析2016年1月至2016年12月在巴肯特大学医院麻醉外科重症监护病房分离的XDR细菌患者资料。18岁以上的成年患者,在入院前24小时内接受手术,并在入住重症监护室48小时后发生重症监护室感染,均被纳入研究。结果:在研究期间,所有341例入住外科重症监护病房的患者均在24小时内接受了手术。341例患者中有30例(9%)分离出XDR细菌感染。APACHE II平均评分为18.5±5.3,预期平均死亡率为35±17.1。重症监护病房平均住院时间27.0±27.4天,住院时间49.0±34.3天。医院死亡率为57% (n=7)。结论:作为我们研究的结论,我们发现重症外科患者中XDR细菌感染很常见(9%),其死亡率高于重症监护病房入院时计算的APACHE II评分的预期死亡率(分别为57%对35%)。
{"title":"The Effect of Extensively Drug-resistant Infections on Mortality in Surgical Intensive Care Patients","authors":"Helin Şahintürk, A. Ozdemirkan, F. Kilic, Onur Ozalp, H. Arslan, P. Zeyneloğlu, A. Pirat","doi":"10.4274/TYBD.73636","DOIUrl":"https://doi.org/10.4274/TYBD.73636","url":null,"abstract":"Objective: The aim of the study was to assess the outcomes of intensive care unit acquired extensively drug-resistant (XDR) bacterial infections in a surgical patient cohort. Materials and Methods: The data of patients with XDR bacteria isolated at Başkent University Hospital, Anesthesia and Surgical Intensive Care Unit between January 2016 and December 2016 were reviewed retrospectively. Adult patients over 18 years of age who had undergone surgery within the first 24 hours and who developed intensive care unit infection 48 hours after admission to intensive care unit were included in the study. Results: All of the 341 patients who admitted to the surgical intensive care unit during the study period were underwent surgery within the first 24 hours. XDR bacterial infections were isolated in 30 out (9%) of these 341 patients. The mean APACHE II score was calculated as 18.5±5.3, and expected mean mortality rate of 35±17.1. The mean length of intensive care unit stay was 27.0±27.4 days, while the mean hospital stay was 49.0±34.3 days. The hospital mortality rate was found to be 57% (n=7). Conclusion: As a conclusion of our study, we found that XDR bacterial infections were common (9%) among intensive care surgical patients and their mortality rate was higher than their expected mortality rate according to their APACHE II scores calculated during intensive care unit admission (57% vs. 35%, respectively).","PeriodicalId":392452,"journal":{"name":"Türk Yoğun Bakım Dergisi","volume":"23 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128251307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Does Early Apnea Test Have an Effect on the Organ Donation? 早期呼吸暂停测试对器官捐献有影响吗?
Pub Date : 2018-07-16 DOI: 10.4274/tybd.36854
Ayşe Güsün Halitoğlu, Mukaddes Saba Saygılı, A. Kaya, M. Tercan
Objective: This study aims to determine the extent to which the timing of apnea test has influence on the organ donation of those patients diagnosed with the brain death (BD) at University of Health Sciences, Şanlıurfa Mehmet Akif İnan Training and Research Hospital between the years of 2006-2017. Materials and Methods: One hundred and five patients diagnosed with BD between the years of 2006-2017 were analyzed retrospectively. Since the sample is limited to the national population, 13 Syrian cases are excluded from the study. The demographic characteristics of the cases, their clinical diagnoses, elapsed time between intensive care hospitalization and apnea test, duration between apnea test and cardio-circulatory arrest, elapsed time between apnea test and BD council decision time, Glasgow coma scores at first visit, APACHE II scores were recorded. Results: Of the ninety two cases evaluated in the study, 33 (35.9%) were female and 59 (64.1%) were male. While the most frequent diagnosis during the admission to the intensive care unit was trauma with 52.2% (n=48), the rest was found as stroke with 35.9% (n=33), anoxic brain injury after cardiopulmonary resuscitation with 6.5% (n=6), and asphyxia with 5.4% (n=5) respectively. Among the patients who have been diagnosed with BD, 12% of the family accepted organ donation. In the cases who accept organ donation; the median time from the first hospitalization in the intensive care unit to the time that the apnea test was positive is 57 hours whereas the median time is 86.8 hours when the organ donation is rejected (p>0.05). Conclusion: Whereas the number of patients diagnosed with BD in our hospital increases over the years, the organ donation rate is insufficient compared to the western part of the country.
目的:本研究旨在确定2006-2017年健康科学大学Şanlıurfa Mehmet Akif İnan培训与研究医院的呼吸暂停测试时间对脑死亡(BD)患者器官捐赠的影响程度。材料与方法:回顾性分析2006-2017年间诊断为BD的105例患者。由于样本仅限于全国人口,13例叙利亚病例被排除在研究之外。记录病例的人口学特征、临床诊断、重症监护住院至呼吸暂停测试的间隔时间、呼吸暂停测试至心脏循环骤停的间隔时间、呼吸暂停测试至BD委员会决定时间的间隔时间、首次就诊时格拉斯哥昏迷评分、APACHE II评分。结果:本组92例患者中,女性33例(35.9%),男性59例(64.1%)。重症监护病房入院时最常见的诊断是外伤,占52.2% (n=48),其余分别为中风(35.9%)(n=33)、心肺复苏后缺氧脑损伤(6.5%)(n=6)和窒息(5.4%)(n=5)。在被诊断为双相障碍的患者中,12%的家庭接受了器官捐赠。接受器官捐献的;从首次入住重症监护病房到呼吸暂停试验阳性的中位数时间为57小时,而器官捐献被拒绝的中位数时间为86.8小时(p>0.05)。结论:我院BD患者逐年增加,但器官捐献率与西部地区相比仍显不足。
{"title":"Does Early Apnea Test Have an Effect on the Organ Donation?","authors":"Ayşe Güsün Halitoğlu, Mukaddes Saba Saygılı, A. Kaya, M. Tercan","doi":"10.4274/tybd.36854","DOIUrl":"https://doi.org/10.4274/tybd.36854","url":null,"abstract":"Objective: This study aims to determine the extent to which the timing of apnea test has influence on the organ donation of those patients diagnosed with the brain death (BD) at University of Health Sciences, Şanlıurfa Mehmet Akif İnan Training and Research Hospital between the years of 2006-2017. Materials and Methods: One hundred and five patients diagnosed with BD between the years of 2006-2017 were analyzed retrospectively. Since the sample is limited to the national population, 13 Syrian cases are excluded from the study. The demographic characteristics of the cases, their clinical diagnoses, elapsed time between intensive care hospitalization and apnea test, duration between apnea test and cardio-circulatory arrest, elapsed time between apnea test and BD council decision time, Glasgow coma scores at first visit, APACHE II scores were recorded. Results: Of the ninety two cases evaluated in the study, 33 (35.9%) were female and 59 (64.1%) were male. While the most frequent diagnosis during the admission to the intensive care unit was trauma with 52.2% (n=48), the rest was found as stroke with 35.9% (n=33), anoxic brain injury after cardiopulmonary resuscitation with 6.5% (n=6), and asphyxia with 5.4% (n=5) respectively. Among the patients who have been diagnosed with BD, 12% of the family accepted organ donation. In the cases who accept organ donation; the median time from the first hospitalization in the intensive care unit to the time that the apnea test was positive is 57 hours whereas the median time is 86.8 hours when the organ donation is rejected (p>0.05). Conclusion: Whereas the number of patients diagnosed with BD in our hospital increases over the years, the organ donation rate is insufficient compared to the western part of the country.","PeriodicalId":392452,"journal":{"name":"Türk Yoğun Bakım Dergisi","volume":"86 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127135727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Can Levosimendan Be a Treatment Option in Subarachnoid Hemorrhage? 左西孟旦可以作为蛛网膜下腔出血的治疗选择吗?
Pub Date : 2018-07-16 DOI: 10.4274/TYBD.05025
T. Mengi, B. Yılmaz, A. N. Gokmen, U. Koca
Despite improvements in medical and surgical treatment, aneurysmatic subarachnoid hemorrhage (SAH) remains one of the main causes of early mortality. Cardiac and pulmonary complications are the main causes of mortality. One of the most severe cardiac complications is neurogenic stress cardiomyopathy. Left ventricular dysfunction which is seen in neurogenic stress cardiomyopathy, although it is usually reversible within a few days, can cause severe hypotension, pulmonary edema and cardiogenic shock. Traditional treatment of heart failure after SAH is based on the use of noradrenaline, dobutamine and high volume of fluids. However, it is difficult to treat reduced cardiac output in SAH. Because, myocardial cells are already under stress due to increased adrenergic stimulation. The use of exogenous catecholamines may cause additional neurocardiogenic damage in myocardial cells, excessive calcium burden, decreased cerebral blood flow, and delayed cerebral ischemia. By reducing the use of exogenous catecholamines with levosimendan, the vicious circle of cardiotoxicity induced by catecholamines can be broken. Levosimendan is a nonadrenergic inotropic calcium sensitizer that allows rapid recovery of cardiac output and optimizes cerebral perfusion without increasing myocardial oxygen consumption. If we consider that reduction in left ventricular systolic function plays a role in the pathogenesis of delayed cerebral ischemia, the risk of developing neurological complications may be reduced by administration of levosimendan in these patients. Moreover, new evidence from experimental studies also indicates that levosimendan may have neuroprotective effects in the SAH. In this review, the use of levosimendan in the treatment of hemodynamic disorders which develops in the course of SAH has been discussed in company with current literature.
尽管医学和外科治疗有所改善,动脉瘤性蛛网膜下腔出血(SAH)仍然是早期死亡的主要原因之一。心肺并发症是死亡的主要原因。最严重的心脏并发症之一是神经源性应激性心肌病。左心室功能障碍见于神经源性应激性心肌病,虽然通常在几天内可逆转,但可引起严重低血压、肺水肿和心源性休克。SAH后心力衰竭的传统治疗是基于使用去甲肾上腺素、多巴酚丁胺和大量液体。然而,SAH的心输出量减少很难治疗。因为心肌细胞由于肾上腺素能刺激的增加已经处于应激状态。外源性儿茶酚胺的使用可能引起心肌细胞额外的神经心源性损伤、钙负担过重、脑血流量减少和脑缺血延迟。通过左西孟旦减少外源性儿茶酚胺的使用,可以打破儿茶酚胺引起的心脏毒性恶性循环。左西孟旦是一种非肾上腺素能性肌力钙增敏剂,可使心输出量快速恢复,并在不增加心肌耗氧量的情况下优化脑灌注。如果我们考虑到左心室收缩功能的降低在延迟性脑缺血的发病机制中起作用,那么左西孟旦可能会降低这些患者发生神经系统并发症的风险。此外,来自实验研究的新证据也表明左西孟旦可能对SAH具有神经保护作用。在这篇综述中,我们结合现有文献讨论了左西孟旦在治疗SAH过程中出现的血流动力学障碍中的应用。
{"title":"Can Levosimendan Be a Treatment Option in Subarachnoid Hemorrhage?","authors":"T. Mengi, B. Yılmaz, A. N. Gokmen, U. Koca","doi":"10.4274/TYBD.05025","DOIUrl":"https://doi.org/10.4274/TYBD.05025","url":null,"abstract":"Despite improvements in medical and surgical treatment, aneurysmatic subarachnoid hemorrhage (SAH) remains one of the main causes of early mortality. Cardiac and pulmonary complications are the main causes of mortality. One of the most severe cardiac complications is neurogenic stress cardiomyopathy. Left ventricular dysfunction which is seen in neurogenic stress cardiomyopathy, although it is usually reversible within a few days, can cause severe hypotension, pulmonary edema and cardiogenic shock. Traditional treatment of heart failure after SAH is based on the use of noradrenaline, dobutamine and high volume of fluids. However, it is difficult to treat reduced cardiac output in SAH. Because, myocardial cells are already under stress due to increased adrenergic stimulation. The use of exogenous catecholamines may cause additional neurocardiogenic damage in myocardial cells, excessive calcium burden, decreased cerebral blood flow, and delayed cerebral ischemia. By reducing the use of exogenous catecholamines with levosimendan, the vicious circle of cardiotoxicity induced by catecholamines can be broken. Levosimendan is a nonadrenergic inotropic calcium sensitizer that allows rapid recovery of cardiac output and optimizes cerebral perfusion without increasing myocardial oxygen consumption. If we consider that reduction in left ventricular systolic function plays a role in the pathogenesis of delayed cerebral ischemia, the risk of developing neurological complications may be reduced by administration of levosimendan in these patients. Moreover, new evidence from experimental studies also indicates that levosimendan may have neuroprotective effects in the SAH. In this review, the use of levosimendan in the treatment of hemodynamic disorders which develops in the course of SAH has been discussed in company with current literature.","PeriodicalId":392452,"journal":{"name":"Türk Yoğun Bakım Dergisi","volume":"34 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121153012","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Türk Yoğun Bakım Dergisi
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1